Literature DB >> 10367627

Procalcitonin as a marker of severity in septic shock.

J Schröder1, K H Staubach, P Zabel, F Stüber, B Kremer.   

Abstract

BACKGROUND/AIMS: Procalcitonin (PCT) was shown to be related to the severity of bacterial infection and is recommended as a new parameter of inflammation and infection. To evaluate the prognostic value in septic shock, PCT levels were repeatedly determined and compared with tumour necrosis factor-alpha (TNF-alpha)- and interleukin (IL)-6 bioactivity as well as with C-reactive protein (CRP) serum levels. PATIENTS: Twenty-four surgical patients with septic shock were included. Eight patients died within the study period of 14 days.
METHODS: Serum levels of TNF-(WEHI 164) and IL-6 (B13-29 subclone 9) bioactivity, CRP and PCT were determined on days 1, 3, 5, 7, 10 and 14 following diagnosis of septic shock.
RESULTS: Survivors and non-survivors were comparable in terms of age and severity of sepsis characterized by the APACHE II score and multiple-organ-failure score. Predominant causes of sepsis were peritonitis and necrotiszing pancreatitis. TNF levels increased in non-survivors with no significant difference to survivors. IL-6 bioactivity was increased on day 1 (P = 0.06) and remained elevated in non-survivors, in whom it was significant on day 7 (P<0.05). CRP was constantly elevated with no difference between the groups. In nonsurvivors PCT remained increased, while the course of survivors was characterized by decreased values which were significantly lower (P<0.05) at every time point compared with those patients who died. A significant correlation could be found on day 1 (P<0.05) and at the end of the observation period (P<0.01) when comparing PCT levels with the multiple-organ-failure score.
CONCLUSIONS: PCT seems to be a more reliable prognostic parameter in septic shock than IL-6, while TNF and CRP did not show any difference between survivors and non-survivors. These data indicate that PCT may represent a valuable parameter not only in the diagnosis of sepsis but also in the clinical course of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367627     DOI: 10.1007/s004230050170

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  11 in total

1.  Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.

Authors:  Y Heper; E H Akalin; R Mistik; S Akgöz; O Töre; G Göral; B Oral; F Budak; S Helvaci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

Review 2.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

3.  Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.

Authors:  Frank Bloos; John C Marshall; Richard P Dellinger; Jean-Louis Vincent; Guillermo Gutierrez; Emanuel Rivers; Robert A Balk; Pierre-Francois Laterre; Derek C Angus; Konrad Reinhart; Frank M Brunkhorst
Journal:  Crit Care       Date:  2011-03-07       Impact factor: 9.097

4.  Serum Procalcitonin Level Reflects the Severity of Cellulitis.

Authors:  Soo Hyeon Noh; Seok Don Park; Eun Jung Kim
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

5.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome.

Authors:  Pierre Emmanuel Charles; Claire Tinel; Saber Barbar; Serge Aho; Sébastien Prin; Jean Marc Doise; Nils Olivier Olsson; Bernard Blettery; Jean Pierre Quenot
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

6.  An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis.

Authors:  Janos Szederjesi; Emoke Almasy; Alexandra Lazar; Adina Huțanu; Iudita Badea; Anca Georgescu
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

7.  Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients.

Authors:  Baykal Tulek; Habibe Koylu; Fikret Kanat; Ugur Arslan; Faruk Ozer
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

8.  Diffuse postoperative peritonitis -- value of diagnostic parameters and impact of early indication for relaparotomy.

Authors:  F G Bader; M Schröder; P Kujath; E Muhl; H-P Bruch; C Eckmann
Journal:  Eur J Med Res       Date:  2009-11-03       Impact factor: 2.175

9.  Procalcitonin as a prognostic marker for sepsis: a prospective observational study.

Authors:  Saransh Jain; Sanjeev Sinha; Surendra K Sharma; J C Samantaray; Praveen Aggrawal; Naval Kishore Vikram; Ashutosh Biswas; Seema Sood; Manish Goel; Madhuchhanda Das; Sreenivas Vishnubhatla; Nawaid Khan
Journal:  BMC Res Notes       Date:  2014-07-17

10.  Can acute-phase response biomarkers differentiate infection from inflammation postpediatric cardiac surgery?

Authors:  Bana Agha Nasser; Abdu Rahman Mesned; Mohamad Tageldein; Mohamed S Kabbani; Nada Siddig Sayed
Journal:  Avicenna J Med       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.